Your browser doesn't support javascript.
loading
Exercised-based cardiac rehabilitation associates with lower all-cause mortality in patients with primary pulmonary hypertension.
Kleinnibbelink, Geert; Buckley, Benjamin J R; Harrison, Stephanie L; Williams, Nefyn; Fazio-Eynullayeva, Elnara; Underhill, Paula; van Dijk, Arie P J; Lip, Gregory Y H; Thijssen, Dick H J.
Afiliación
  • Kleinnibbelink G; Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, United Kingdom.
  • Buckley BJR; Research Institute for Health Sciences, Departments of Physiology and Cardiology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Harrison SL; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.
  • Williams N; Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.
  • Fazio-Eynullayeva E; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.
  • Underhill P; Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.
  • van Dijk APJ; Department of Primary Care and Mental Health, University of Liverpool, Liverpool, United Kingdom.
  • Lip GYH; TriNetX LLC., Cambridge, MA, United States.
  • Thijssen DHJ; TriNetX LLC., London, United Kingdom.
Front Sports Act Living ; 5: 1247615, 2023.
Article en En | MEDLINE | ID: mdl-38152382
ABSTRACT

Background:

Despite pharmacological therapies to improve outcomes of pulmonary hypertension (PH), poor long-term survival remains. Exercised-based cardiac rehabilitation (ExCR) may be an alternative strategy to improve prognosis. Therefore, using an electronic medical record (EMR) database, the objective of this study was to compare mortality between patients with primary PH with ExCR vs. propensity-matched PH patients without ExCR.

Methods:

The retrospective analysis was conducted on February 15, 2023 using anonymized data within TriNetX, a global federated health research network. All patients were aged ≥18 years with primary PH recorded in EMRs with at least 1-year follow-up from ExCR. Using logistic regression models, patients with PH with an EMR of ExCR were 11 propensity score-matched with PH patients without ExCR for age, sex, race, and comorbidities, and cardiovascular care.

Results:

In total, 109,736 patients with primary PH met the inclusion criteria for the control group and 784 patients with primary PH met the inclusion criteria for the ExCR cohort. Using the propensity score-matched cohorts, 1-year mortality from ExCR was proportionally lower with 13.6% (n = 101 of 744 patients) in the ExCR cohort compared to 23.3% (n = 174 of 747 patients) in the controls (OR 0.52, 95% CI 0.40-0.68).

Conclusion:

The present study of 1,514 patients with primary PH suggests that ExCR is associated with 48% lower odds of 1-year mortality, when compared to propensity score-matched patients without ExCR.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Sports Act Living Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Sports Act Living Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido